Atlas Trials

Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole

Clinical trial NCT02986685 · WITHDRAWN

Trial details

NCT number
NCT02986685
Sponsor
Xijing Hospital of Digestive Diseases
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Refractory Reflux Esophagitis
Start date
2016-11-01
Primary completion
2017-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.